Psychiatric disorders in pregnancy

[1]  Jennita Reefhuis,et al.  Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. , 2007, The New England journal of medicine.

[2]  B. Haight,et al.  Bupropion in pregnancy and the prevalence of congenital malformations , 2007, Pharmacoepidemiology and drug safety.

[3]  B. Källén,et al.  Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. , 2007, Birth defects research. Part A, Clinical and molecular teratology.

[4]  S. Hernández-Díaz,et al.  Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.

[5]  G. Koren,et al.  Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. , 2005, The Journal of clinical psychiatry.

[6]  P. Hallberg,et al.  The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feeding: A Review and Clinical Aspects , 2005, Journal of clinical psychopharmacology.

[7]  L. Altshuler,et al.  Reintroduction of Antidepressant Therapy across Pregnancy in Women Who Previously Discontinued Treatment , 2004, Psychotherapy and Psychosomatics.

[8]  L. Altshuler,et al.  Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. , 1996, The American journal of psychiatry.

[9]  L. Sever,et al.  Teratogen update: valproic acid. , 1987, Teratology.

[10]  Shiono Ph,et al.  Oral clefts and diazepam use during pregnancy. , 1984 .

[11]  M. Weinstein,et al.  Cardiovascular malformations with lithium use during pregnancy. , 1975, The American journal of psychiatry.

[12]  M. Schou,et al.  Lithium and pregnancy. I. Report from the Register of Lithium Babies. , 1973, British medical journal.